State of China Life Science: 2018 H1

The life science sector in China reached unprecedented VC investment activity in 2017. The VC explosion continues in 2018, positioning this sector for yet another trendsetting year in investment activity.

• M&A activity is on track for another record-breaking year, with a forecasted USD 27 billion in deal value by the end of the year.
• USD 80 billion has been raised in VC funding over the last three years.
• Partnering deals are also expected to hit a new record high, with deal value projected to surpass USD 10 billion by the end of the year.

Review the latest analysis of the life science investment activity. Download your copy here.